Anumana Acquires NeuTrace, an AI-Electrophysiology Company

See Release


Anumana is growing! Are you passionate about improving outcomes for heart disease patients and delivering early-detection solutions to the market?

Anumana is harnessing industry-leading AI and translational science to decode the electrocardiogram (ECG) as never before — as a deep predictive tool and biomarker of disease to empower care providers to help patients with early detection of heart disease.

Anumana is hiring experienced and skilled individuals for key positions on the team. You can see our full list of available positions and apply on LinkedIn.

Partner with us!

We’re actively developing algorithms for FDA approval. Please direct partnership and media inquiries to

@2022 anumana, Inc. All rights reserved.